ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Short term Debt (2016 - 2026)

Updated

ProPhase Labs (PRPH) posted Short term Debt of $438,000 for Q2 2026, up 44.1% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Short term Debt (2016 - 2026) Analysis & Trends

At the end of FY2025, ProPhase Labs' Short term Debt came in at $244,000.

  • Quarterly Short term Debt has run from a low of $244,000 in Q4 2025 to a high of $517,000 in Q3 2025 over five years.
  • According to Business Quant data, Short term Debt for the three prior quarters was $304,000 (Q1 2026), $244,000 (Q4 2025) and $517,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 438,000.00
Mar 31, 2026 304,000.00
Dec 31, 2025 244,000.00
Sep 30, 2025 517,000.00
Dec 31, 2016 1.49 Mn
Jun 30, 2016 1.48 Mn
API Access

ProPhase Labs Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PRPH&period=max&api_key=YOUR_API_KEY